Answer
Galvus (vildagliptin) should not be used in people with hepatic impairment, including those whose pre-treatment ALT or AST liver enzyme levels exceed three times the upper limit of normal.
Sources for this answer
- Galvus 50 mg TabletsNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 24Document updated
Sources checked